A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
Clinical trial NCT03106324 · COMPLETED
Trial details
- NCT number
- NCT03106324
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-31
- Primary completion
- 2026-01-14
- Enrollment
- 911
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.